SEC Form 4 · accession 0000899243-18-022515
Wave Life Sciences, Inc. · WVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Kolchinsky
Director · 10% Owner
Period of report
Aug 13, 2018
Accepted (ET)
Aug 15, 2018 · 8:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631574
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy)F1 | $46.70 | Aug 13, 2018 | A | 9,000 | A | — | Aug 13, 2023 | Ordinary Shares | 9,000 | 9,000 | D |
Explanation of responses
- F1The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on August 13, 2019.